Denali Therapeutics
DNLI
#3955
Rank
NZ$3.81 B
Marketcap
$26.29
Share price
1.23%
Change (1 day)
4.73%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2023 (TTM): -$1.71

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.76. In 2022 the company made an earnings per share (EPS) of -$4.36 a decrease over its 2021 EPS that were of -$4.01.

EPS history for Denali Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.71-60.75%
2022-$4.368.79%
2021-$4.01-712.82%
2020$0.65-118.93%
2019-$3.45402.44%
2018-$0.69-88.89%
2017-$6.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.12 77.14% Jersey
-$12.06 584.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.45 96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.40 490.48%๐Ÿ‡ฌ๐Ÿ‡ง UK